A detailed history of Horizon Investments, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 27,336 shares of INVA stock, worth $608,226. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,336
Previous 24,445 11.83%
Holding current value
$608,226
Previous $491,000 1.43%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$18.17 - $20.92 $52,529 - $60,479
2,891 Added 11.83%
27,336 $498,000
Q2 2025

Aug 13, 2025

BUY
$17.1 - $21.8 $418,009 - $532,901
24,445 New
24,445 $491,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.55B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.